Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for HR+ Premenopausal Breast Cancer

NCT07180914 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for HR+ Premenopausal Breast Cancer
Lead sponsor
Zhejiang Cancer Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 10, 2025
Completion date
December 31, 2029
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer females